These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 28371476)

  • 1. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
    Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
    Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.
    Giorgetti A; Mogler L; Haschimi B; Halter S; Franz F; Westphal F; Fischmann S; Riedel J; Pütz M; Auwärter V
    Drug Test Anal; 2020 Jan; 12(1):78-91. PubMed ID: 31476105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry).
    Szpot P; Nowak K; Wachełko O; Tusiewicz K; Chłopaś-Konowałek A; Zawadzki M
    Forensic Toxicol; 2023 Jan; 41(1):47-58. PubMed ID: 36652054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA.
    Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V
    Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid.
    Tokarczyk B; Jurczyk A; Krupińska J; Adamowicz P
    Forensic Sci Med Pathol; 2022 Dec; 18(4):393-402. PubMed ID: 35699867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of four amide synthetic cannabinoid isomers by ultra-high performance liquid chromatography-high resolution mass spectrometry].
    Tang R; Wang J; Xiao T; Qin S; Jie Z; Zhang A
    Se Pu; 2024 Jan; 42(1):84-91. PubMed ID: 38197209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
    Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
    AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
    Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
    Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
    Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GC-MS/MS analysis of synthetic cannabinoids 5F-MDMB-PICA and 5F-CUMYL-PICA in forensic cases.
    Ahmed H; Mujeebuddin S
    Bioanalysis; 2024; 16(9):401-413. PubMed ID: 38466892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples.
    Mogler L; Wilde M; Huppertz LM; Weinfurtner G; Franz F; Auwärter V
    Drug Test Anal; 2018 May; 10(5):886-891. PubMed ID: 29314750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018.
    Liu C; Jia W; Hua Z; Qian Z
    Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focusing on the 5F-MDMB-PICA, 4F-MDMB-BICA synthetic cannabinoids and their primary metabolites in analytical and pharmacological aspects.
    Dvorácskó S; Körmöczi T; Sija É; Bende B; Weiczner R; Varga T; Ilisz I; Institóris L; Kereszty ÉM; Tömböly C; Berkecz R
    Toxicol Appl Pharmacol; 2023 Jul; 470():116548. PubMed ID: 37182749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of the synthetic cannabinoid 5F-PY-PICA by human and rat hepatocytes and identification of biliary analytical targets by directional efflux in sandwich-cultured rat hepatocytes using UHPLC-HR-MS/MS.
    Mardal M; Annaert P; Noble C; Oorts M; Linnet K
    J Pharm Biomed Anal; 2018 Feb; 149():296-307. PubMed ID: 29128830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feature-Based Molecular Network for New Psychoactive Substance Identification: The Case of Synthetic Cannabinoids in a Seized e-Liquid and Biological Samples.
    Magny R; Lefrère B; Roulland E; Auzeil N; Farah S; Richeval C; Gish A; Vodovar D; Labat L; Houzé P
    J Am Soc Mass Spectrom; 2024 Oct; 35(10):2276-2287. PubMed ID: 39186500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue.
    Sobolevsky T; Prasolov I; Rodchenkov G
    Drug Test Anal; 2015 Feb; 7(2):131-42. PubMed ID: 25428705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.